Clinical Trial Update: Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

View source ↗

Summary

This completed clinical trial evaluated patient management practices and quality of life for paricalcitol capsules in treating secondary hyperparathyroidism in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease | Status: COMPLETED | Results posted: 2014-02-19